Persica's antibiotic-based drug could benefit patients with chronic lower back pain who are suffering from an infection in ...

THE WOODLANDS, Texas, March 06, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today reported financial results for the three months and year ended December 31, 2024, and ...

F or horses (and horse owners) who struggle with it, trigeminal nerve-mediated head-shaking can be a challenge. Horses who ...

On a 0-10 pain scale, the hydrodissection group reported an average pain reduction of 4 points ... While the technique has shown promise for acute and neuropathic pain, its effectiveness for ...

On a 0–10 pain scale, the hydrodissection group reported an average pain reduction of 4 points ... While the technique has shown promise for acute and neuropathic pain, its effectiveness for ...

The clinical profile encompasses variables such as age (ranging between 10 and 97 years), gender (male/female), the specific pathology diagnosed (e.g., central nervous system disorders, rheumatoid ...

(1) “Efficacy and Safety of ATX01 in Adult Patients With CIPN (Chemotherapy-induced Peripheral Neuropathy) (ACT)”. The purpose of this clinical trial is to compare the efficacy of twice daily ...

PARIS, Feb. 18, 2025 (GLOBE NEWSWIRE) -- AlgoTherapeutix (AlgoTx), a clinical stage biotechnology company developing a first-in-class therapeutic for peripheral neuropathic pain, ATX01, announced ...

PARIS, Feb. 18, 2025 (GLOBE NEWSWIRE) -- AlgoTherapeutix (AlgoTx), a clinical stage biotechnology company developing a first-in-class therapeutic for peripheral neuropathic pain, ATX01 ...